These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 29594318)

  • 1. Adrenal crisis after first infusion of zoledronic acid: a case report.
    Smrecnik M; Kavcic Trsinar Z; Kocjan T
    Osteoporos Int; 2018 Jul; 29(7):1675-1678. PubMed ID: 29594318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adrenal Crisis as An Adverse Reaction to Zoledronic Acid in a Patient With Primary Adrenal Insufficiency: A Case Report and Literature Review.
    Kuo B; Koransky A; Vaz Wicks CL
    AACE Clin Case Rep; 2023; 9(2):32-34. PubMed ID: 37056413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicenter Study on Observation of Acute-phase Responses After Infusion of Zoledronic Acid 5 mg in Chinese Women with Postmenopausal Osteoporosis.
    Ding Y; Zeng JC; Yin F; Zhang CL; Zhang Y; Li SX; Liu X; Zhang C; Xue QY; Lin H; Pei FX
    Orthop Surg; 2017 Aug; 9(3):284-289. PubMed ID: 28960821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Metabolic assessment of hydrocortisone replacement therapy in patients with primary adrenocortical insufficiency].
    Fichna M; Gryczyńska M; Sowińska A; Sowiński J
    Przegl Lek; 2011; 68(2):96-102. PubMed ID: 21751518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Addison's disease].
    Quinkler M
    Med Klin Intensivmed Notfmed; 2012 Sep; 107(6):454-9. PubMed ID: 22907517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Once-yearly administered intravenous zoledronic acid for postmenopausal osteoporosis.
    Woodis CB
    Ann Pharmacother; 2008 Jul; 42(7):1085-9. PubMed ID: 18505912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of single-dose dexamethasone on acute phase response following zoledronic acid: a randomized controlled trial.
    Billington EO; Horne A; Gamble GD; Maslowski K; House M; Reid IR
    Osteoporos Int; 2017 Jun; 28(6):1867-1874. PubMed ID: 28233020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vertebral fractures assessed with dual-energy X-ray absorptiometry in patients with Addison's disease on glucocorticoid and mineralocorticoid replacement therapy.
    Camozzi V; Betterle C; Frigo AC; Zaccariotto V; Zaninotto M; De Caneva E; Lucato P; Gomiero W; Garelli S; Sabbadin C; Salvà M; Costa MD; Boscaro M; Luisetto G
    Endocrine; 2018 Feb; 59(2):319-329. PubMed ID: 28795340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of and risk factors for the acute-phase response after zoledronic acid.
    Reid IR; Gamble GD; Mesenbrink P; Lakatos P; Black DM
    J Clin Endocrinol Metab; 2010 Sep; 95(9):4380-7. PubMed ID: 20554708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis.
    Black DM; Delmas PD; Eastell R; Reid IR; Boonen S; Cauley JA; Cosman F; Lakatos P; Leung PC; Man Z; Mautalen C; Mesenbrink P; Hu H; Caminis J; Tong K; Rosario-Jansen T; Krasnow J; Hue TF; Sellmeyer D; Eriksen EF; Cummings SR;
    N Engl J Med; 2007 May; 356(18):1809-22. PubMed ID: 17476007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent nocturnal hypoglycaemia as a cause of morning fatigue in treated Addison's disease--favourable response to dietary management: a case report.
    Petersen KS; Rushworth RL; Clifton PM; Torpy DJ
    BMC Endocr Disord; 2015 Oct; 15():61. PubMed ID: 26500000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bisphosphonate-induced orbital inflammation in a patient on chronic immunosuppressive therapy.
    Herrera I; Kam Y; Whittaker TJ; Champion M; Ajlan RS
    BMC Ophthalmol; 2019 Feb; 19(1):51. PubMed ID: 30764790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous Zoledronic Acid 5 mg on Bone Turnover Markers and Bone Mineral Density in East China Subjects with Newly Diagnosed Osteoporosis: A 24-month Clinical Study.
    Liang BC; Shi ZY; Wang B; Wu P; Kong LC; Yao JL; Li CW; Shi XL
    Orthop Surg; 2017 Feb; 9(1):103-109. PubMed ID: 28276638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1-34)] in postmenopausal osteoporosis.
    Cosman F; Eriksen EF; Recknor C; Miller PD; Guañabens N; Kasperk C; Papanastasiou P; Readie A; Rao H; Gasser JA; Bucci-Rechtweg C; Boonen S
    J Bone Miner Res; 2011 Mar; 26(3):503-11. PubMed ID: 20814967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone mineral density in patients with treated Addison's disease.
    Braatvedt GD; Joyce M; Evans M; Clearwater J; Reid IR
    Osteoporos Int; 1999; 10(6):435-40. PubMed ID: 10663342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokines and insulin resistance after zoledronic acid-induced acute phase response.
    Kassi G; Papamichael K; Papaioannou G; Giagourta I; Thanou S; Triantaphyllopoulou M; Zapanti E; Papandroulaki F; Ktena V; Karga H
    Immunol Invest; 2014; 43(6):544-55. PubMed ID: 24661204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of non-steroidal anti-inflammatory drugs on zoledronic acid-induced acute-phase reactions: randomized, open-label, Japanese OZ study.
    Okimoto N; Sakai A; Yoshioka T; Kobayashi T; Asano K; Akahoshi S; Ishikura T; Fukuhara S; Fuse Y; Mizuno T; Katae Y; Matsumoto H; Ogawa T; Nishida S; Ikeda S; Menuki K; Saito J; Okazaki Y; Mizuno N; Fujiwara S
    J Bone Miner Metab; 2020 Mar; 38(2):230-239. PubMed ID: 31586241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New onset Addison's disease presenting as prolonged hyperemesis in early pregnancy.
    Lewandowski K; Hincz P; Grzesiak M; Cajdler-Łuba A; Salata I; Wilczyński J; Lewiński A
    Ginekol Pol; 2010 Jul; 81(7):537-40. PubMed ID: 20825057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addison's disease in Africa--a teaching hospital experience.
    Soule S
    Clin Endocrinol (Oxf); 1999 Jan; 50(1):115-20. PubMed ID: 10341864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversible cardiomyopathy in paediatric Addison's disease--a cautionary tale.
    Conwell LS; Gray LM; Delbridge RG; Thomsett MJ; Batch JA
    J Pediatr Endocrinol Metab; 2003; 16(8):1191-5. PubMed ID: 14594181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.